إعلان
إعلان

TGTX

TGTX logo

TG Therapeutics, Inc.

30.50
USD
برعاية
+0.16
+0.54%
٠٨ يناير, ١٦:٠٠ UTC -5
مغلق
exchange

بعد الإغلاق

30.49

-0.02
-0.05%

تقارير أرباح TGTX

النسبة الإيجابية المفاجئة

TGTX تفوق 12 من 40 آخر التقديرات.

30%

التقرير التالي

بيانات التقرير القادم
--
Estimate for Q-- -- (Revenue/ EPS)
--
/
--
التغير الضمني من Q3 25 (Revenue/ EPS)
--
/
--
التغير الضمني من Q-- -1 (Revenue/ EPS)
--
/
--

TG Therapeutics, Inc. earnings per share and revenue

On ٠٣ نوفمبر ٢٠٢٥, TGTX reported earnings of 0.16 USD per share (EPS) for Q3 25, missing the estimate of 0.22 USD, resulting in a -28.70% surprise. Revenue reached 161.71 مليون, compared to an expected 155.21 مليون, with a 4.19% difference. The market reacted with a -3.13% price change (close before vs. close after earnings).
Looking ahead to -- --, -- المحللين forecast an EPS of -- USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.
الأسئلة الشائعة
For Q3 2025, TG Therapeutics, Inc. reported EPS of $0.16, missing estimates by -28.7%, and revenue of $161.71M, 4.19% above expectations.
The stock price moved down -3.13%, changed from $34.78 before the earnings release to $33.69 the day after.
The next earning report is scheduled for --.
Based on -- المحللين, TG Therapeutics, Inc. is expected to report EPS of -- and revenue of -- for Q-- --.
شيك FXEmpire's Earnings Calendar for today's list of reporting companies.
إعلان